Unknown PHASE1/PHASE2 INTERVENTIONAL 4-arm NCT02148016

Corneal Epithelium Repair and Therapy Using Autologous Limbal Stem Cell Transplantation

Sponsor: Sun Yat-sen University

Conditions Corneal Disease Hyperopia Myopia Pterygium

Interventions Amniotic membrane only (Traditional Technique) Betamethasone LSCs and amniotic membrane (Modified Technique) Levofloxacin Limbal stem cells (LSCs) PRK only (Traditional Technique) PRK, LSCs, and amniotic membrane (Modified Technique)

Updated 5 times since 2017 Last updated: May 27, 2014 Started: Dec 31, 2012 Primary completion: Jun 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Corneal Disease and Hyperopia, this trial is ongoing. The trial is conducted by Sun Yat-sen University and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sun Yat-sen University

Data source: Sun Yat-sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China